ADC Therapeutics SA
Veridion Score
Composite trend over time
Why is ADCT moving today?
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ADCT.
ADCT insider activity
ADC Therapeutics SA
No multi-insider buying cluster in the last 90 days
Net buying: $15.4M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | 2026-06-03 | Monges Viviane | Insider | sell | $3.08 | 2,596 | 186,447 | $8K | SEC Form 4 |
| 2026-06-03 | 2026-06-03 | Hug Peter | Insider | sell | $3.08 | 2,156 | 263,344 | $7K | SEC Form 4 |
| 2026-06-03 | 2026-06-03 | Azelby Robert | Insider | sell | $3.08 | 12,600 | 112,805 | $39K | SEC Form 4 |
| 2026-06-03 | 2026-06-03 | BIZZARI JEAN-PIERRE | Insider | sell | $3.08 | 12,600 | 139,302 | $39K | SEC Form 4 |
| 2026-06-03 | 2026-06-03 | Sandor Victor | Insider | sell | $3.08 | 12,600 | 140,686 | $39K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 25 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moADCT contract awards, year to date.
Public federal awards linked to this ticker.
ADCT lobbying filings, year to date.
Registered lobbying filings matched to ADC Therapeutics SA.